Contact

✓ Last verified: April 18, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Metropolitan Institute of Pain Chicago in Chicago, Illinois logo

Known For: High-volume ketamine practice reporting 70%+ success rate and over 2,000 patients treated, with three Chicagoland locations specializing in treatment-resistant depression

Google ReviewsPositive Yelp reviews
LocationFulton Market, Chicago, Illinois
Address312 N May St, Suite 110, Chicago, IL 60607
Phone(312) 757-4647 (general); (312) 690-5689 (new patients)
Websitemipainchicago.com
TreatmentsLow-Dose IV Ketamine Infusions, Comprehensive Pain Management
ConditionsTreatment-Resistant Depression, Anxiety, Chronic Pain
CostContact clinic; superbill provided for potential reimbursement
InsuranceSelf-pay; superbill available for insurance reimbursement
KAP AvailableContact clinic
Clinical LeadDr. Shoeb (Ketamine Program); Dr. Murtaza (Pain Management)

HealingMaps Take: Metropolitan Institute of Pain brings serious volume and data to their ketamine program — over 2,000 patients treated with a reported 70%+ success rate. They specifically target treatment-resistant patients who haven’t responded to SSRIs, SNRIs, tricyclics, MAOIs, ECT, or TMS. Their Fulton Market location is complemented by offices in Orland Park and Arlington Heights. A notable advantage is their willingness to provide superbills for potential insurance reimbursement, which can help offset the self-pay cost.

Market Position: Metropolitan Institute of Pain is an IV-ketamine-focused clinic in the Chicago metro — the most common cash-pay protocol in the HealingMaps verified directory.

Is Metropolitan Institute of Pain Right for You?

✓ Choose Metropolitan Institute of Pain if:

  • You want supervised IV ketamine with real-time medical monitoring

✗ Look elsewhere if:

  • You need Spravato (FDA-approved esketamine) covered by your insurance
  • You want ketamine-assisted psychotherapy (KAP) with integrated talk therapy

Metropolitan Institute of Pain Ketamine Cost Calculator

How Much Will Ketamine Therapy Cost?

Estimate your out-of-pocket range based on patient-reported pricing and HealingMaps proprietary clinic data.
Estimated per session
$525–$900
Range: $450–$1,500/session
Estimated total program
$3,150–$5,400
Range: $2,700–$9,000/6-session series
Your estimate vs. national patient-reported median Based on national tracking, adjusted for Chicago, IL market
Select a treatment type to see pricing context.

Ketamine Protocols Compared — What’s Offered at Metropolitan Institute of Pain

Industry pricing reference. Metropolitan Institute of Pain has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.

ProtocolTypical Industry CostOffered Here
IV Ketamine$350–$650/session✓ Yes
Spravato (esketamine)$0–$250 copay (insured)—
IM Ketamine$250–$400/injection—
KAP (with therapist)$400–$1,200/session—
At-home troches$150–$300/month—

What to Expect at Your First Metropolitan Institute of Pain Appointment

  1. Initial intake call — Brief medical history review, depression and anxiety screening, and medical clearance for IV ketamine. Call (312) 757-4647 (general); (312) 690-5689 (new patients) to schedule.
  2. Medical evaluation — in-person or telehealth psychiatric assessment, vitals check, and review of current medications with the Metropolitan Institute of Pain clinical team.
  3. First treatment session — supervised IV ketamine infusion in a private treatment room, lasting approximately 60–90 minutes (40-minute infusion + recovery). Sessions are held at 312 N May St, Suite 110, Chicago, IL 60607. You’ll have a comfortable chair or recliner, dim lighting, and direct medical monitoring throughout.
  4. Recovery and follow-up — observation period after dosing, mood check-in with the clinical team, and scheduling your next session. Arrange for a ride home; do not drive for 24 hours after your IV session.

What to Ask on Your Metropolitan Institute of Pain Consult Call

  • How long has the Metropolitan Institute of Pain clinical team been delivering ketamine therapy, and what specialty training do your providers hold?
  • Does Metropolitan Institute of Pain provide a superbill for out-of-network insurance reimbursement, and what’s a typical 6-session total cost including any follow-up?
  • Have you handled BCBS Illinois Spravato prior authorizations, and what’s the typical PA approval timeline?
  • What does Metropolitan Institute of Pain recommend for patients who don’t respond to the standard 6-session acute series?

Patient Questions about Metropolitan Institute of Pain

This 3-question summary is matched to the protocols and conditions Metropolitan Institute of Pain treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.

Is Metropolitan Institute of Pain suited for treatment-resistant depression?

Metropolitan Institute of Pain treats depression via IV ketamine (off-label, evidence-based). Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.

Does Metropolitan Institute of Pain treat chronic pain conditions?

Yes — Metropolitan Institute of Pain treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.

Can Metropolitan Institute of Pain help with anxiety disorders?

Yes — Metropolitan Institute of Pain treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.

Location

Add Review

Leave a Reply

Your email address will not be published. Required fields are marked *

Service
Value for Money
Location
Cleanliness

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healing Maps Editorial Staff

Healing Maps Editorial Staff

View all posts by Healing Maps Editorial Staff

The Healing Maps Editorial Team has decades of experience across all facets of the psychedelic industry. From assessing studies and clinic research, to working with clinician's and clinics, we help provide data-backed information to psychedelic-curious individuals across the globe.

Explore Psychedelic Therapy Regions